Aside from rapid and effective reperfusion, therapeutic agents to minimize infarct size and/or subsequent left ventricle (LV) remodeling are lacking
It is the time to learn what your stomach can tolerate
This is a lifestyle change, not a curse
I generally recommend alternating between local wrist injection and abdominal injection
If your AC1 level is greater than 6.5 percent, diabetes is diagnosed
Todays milestone establishes Ozempic as an option for patients to help address two critical aspects of managing type 2 diabetes, blood sugar control and cardiovascular risk reduction, in those with known heart disease. Changes to Rybelsus Prescribing Information The Rybelsus (semaglutide) prescribing information has been updated in section 14 (clinical studies) to include an analysis from the primary endpoint of the PIONEER 6 CVOT showing the hazard ratio for time to first three-component MACE (HR 0.79 [95% CI: 0.57, 1.11]).[5] In June 2019, Novo Nordisk initiated the SOUL CVOT in 9,642 adults with type 2 diabetes and established cardiovascular disease to further evaluate the cardiovascular effect of Rybelsus
